Table 3

Ischemic stroke treatment metrics

	2020 pandemic cohort: spring (n=206)	2019 reference cohort: spring (n=178)	P value	2020 pandemic cohort: summer (n=177)	2019 reference cohort: summer (n=161)	P value
Stroke evaluation metrics
Symptom onset to hospital presentation delay
All patients	142 (62–348)	101 (59–212)	0.03	110 (52–256)	97 (61–233)	0.73
All ischemic stroke patients	169 (63–353)	116 (62–229)	0.12	110 (50–261)	97 (58–233)	0.91
Door-to-imaging
Direct evaluation	18 (13–23)	16 (10–22)	0.13	19 (14–24)	18 (11–23)	0.19
Transfer from another institution	29 (20–46)	21 (15–31)	0.04	21 (13–34)	21 (14–41)	0.78
Reperfusion metrics
Door-to-needle
Direct evaluation	34 (26–41)	24 (21–30)	0.01	29 (26–39)	24 (21–32)	0.03
Transfer from another institution	52 (43–79)	61 (45–76)	0.55	61 (47–78)	48 (39–65)	0.09
Door-to-puncture
Direct evaluation	68 (60–90)	56 (43–70)	0.03	73 (56–83)	74 (52–79)	0.99
Transfer from another institution (door: referring ED)	147 (133–174)	153 (121–184)	0.88	149 (137–177)	149 (130–185)	0.61
Transfer from another institution (door: CSC ED)	20 (15–24)	16 (11–24)	0.10	18 (16–21)	16 (12–24)	0.18
Door-to-recanalization
Direct evaluation	98 (89–123)	80 (62–95)	0.01	98 (82–115)	104 (90–117)	0.78
Transfer from another institution (door: referring ED)	190 (160–228)	189 (154–230)	0.97	190 (161–206)	183 (162–217)	0.94
Transfer from another institution (door: CSC ED)	50 (37–69)	42 (32–64)	0.25	50 (41–71)	53 (37–69)	0.64